28 Jan Novo Nordisk’s Ozempic wins FDA approval for chronic kidney disease
[ad_1] The Food and Drug Administration on Tuesday approved Novo Nordisk's Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular injection in the U.S. The drug is already widely used and covered to treat...